Calvenza-03 EIV

BOEHRINGER Calvenza-03 EIV Influenza - Single Dose
SKU : 21710
Price: $129.00

Equine influenza vaccine

  • 10 dose vial
  • Killed virus
  • On manufacturer backorder
by Boehringer

For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease caused by equine influenza types A1 and A2 viruses.

Why Calvenza EIV?
  • Incorporates the emerging North American EIV strain (Ohio/2003), as well as an established North American EIV strain (Kentucky/2/95).Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93).
  • Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93).
  • Unique EHV-1 equine respiratory origin isolate.
  • Novel adjuvant.
  • Safe, all killed vaccine.
  • Includes innovative pliable nasal applicator.
  • Flexible dose administration.
  • No reversion to virulence concern.
  • Minimal vaccine site reactions.

Dosage and administration:

  • Shake well before use.
  • Using aseptic technique, inoculate horses intramuscularly with a 2ml dose.
  • Administer a third 2ml dose in 3-4 weeks by either the intramuscular or intranasal route.
  • Revaccinate annually and prior to anticipated exposure, by either the intramuscular or intranasal route.


All Vaccines Now Ship OVERNIGHT Delivery Only at a great LOW Rate!
Vaccines are shipped in a cooling package on Monday-Thursdays (on orders placed before 2:00p.m.)

Click here for Vaccine Shipping Schedule.

Customer Reviews
(0.00)
# of Ratings: 0
by Boehringer

For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease caused by equine influenza types A1 and A2 viruses.

Why Calvenza EIV?
  • Incorporates the emerging North American EIV strain (Ohio/2003), as well as an established North American EIV strain (Kentucky/2/95).Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93).
  • Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93).
  • Unique EHV-1 equine respiratory origin isolate.
  • Novel adjuvant.
  • Safe, all killed vaccine.
  • Includes innovative pliable nasal applicator.
  • Flexible dose administration.
  • No reversion to virulence concern.
  • Minimal vaccine site reactions.

Dosage and administration:

  • Shake well before use.
  • Using aseptic technique, inoculate horses intramuscularly with a 2ml dose.
  • Administer a third 2ml dose in 3-4 weeks by either the intramuscular or intranasal route.
  • Revaccinate annually and prior to anticipated exposure, by either the intramuscular or intranasal route.


All Vaccines Now Ship OVERNIGHT Delivery Only at a great LOW Rate!
Vaccines are shipped in a cooling package on Monday-Thursdays (on orders placed before 2:00p.m.)

Click here for Vaccine Shipping Schedule.

Loading...